Order Article Reprints

Hannani D, Leplus E, Laurin D, Caulier B, Aspord C, Madelon N, Bourova-Flin E, Brambilla C, Brambilla E, Toffart A-C, et al. A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients. International Journal of Molecular Sciences. 2023; 24(3):1897. https://doi.org/10.3390/ijms24031897

Hannani, Dalil, Estelle Leplus, David Laurin, Benjamin Caulier, Caroline Aspord, Natacha Madelon, Ekaterina Bourova-Flin, Christian Brambilla, Elisabeth Brambilla, Anne-Claire Toffart, and et al. 2023. "A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients" International Journal of Molecular Sciences 24, no. 3: 1897. https://doi.org/10.3390/ijms24031897

Hannani, D., Leplus, E., Laurin, D., Caulier, B., Aspord, C., Madelon, N., Bourova-Flin, E., Brambilla, C., Brambilla, E., Toffart, A.-C., Laulagnier, K., Chaperot, L., & Plumas, J. (2023). A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients. International Journal of Molecular Sciences, 24(3), 1897. https://doi.org/10.3390/ijms24031897